ClinicalTrials.gg
CompletedNCT00002304Updated Jun 24, 2005

A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems

An interventional study of Ketoconazole and Fluconazole in Candidiasis, Esophageal and HIV Infections, sponsored by Pfizer. Completed at 42 sites in 2 countries. Open to participants aged 13 Years to 70 Years. Per ClinicalTrials.gov, last updated 2005-06-24.

Sponsored by Pfizer · Not applicable, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Ages
13 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 19 studies testing fluconazole in Candidiasis — 1 open to participants now, 1 under way, none of them phase 3. Fluconazole · Candidiasis.

No phase
5 of 19
1 open now
Registered
1st of 19
by date
Lead sponsor
4 of 19
Pfizer

Among the 19 studies testing fluconazole in Candidiasis, this one is one of 5 with no phase, and was the 1st registered.

Candidiasis

132 studies on the registry are indexed under Candidiasis; 9 are open to participants now.

Browse Candidiasis studies →

Open to participants now

1 of the 19 studies testing fluconazole in Candidiasis is open now, in 3 countries. Recruiting first, the newest first:

By country, each count listing its studies:

About fluconazole

Fluconazole: first FDA approval 1990 (DIFLUCAN). What it is approved for, and how studies give it, is on its page →

Who these studies take

Of the 6 Candidiasis studies recruiting now, 4 set no upper age limit and 2 stop at 75 or younger; 2 take children under 18; 3 take healthy volunteers.

This study: 13 Years to 70 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 19 studies testing fluconazole in Candidiasis, or all of them as a file.
02

Study summary

To compare the safety, tolerance, and effectiveness of fluconazole and ketoconazole in the treatment of candidal esophagitis in immunocompromised patients.

03

Conditions studied

  • Candidiasis, Esophageal
  • HIV Infections

Keywords

  • AIDS-Related Opportunistic Infections
  • Immune Tolerance
  • Ketoconazole
  • Esophagitis
  • Fluconazole
  • Acquired Immunodeficiency Syndrome
  • Candidiasis, Oral
04

Who can participate

Ages eligible
13 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Prior Medication:

Allowed:

  • Cyclosporin if levels can be monitored for proper cyclosporin dose adjustment.

Exclusion criteria

Exclusion Criteria

Co-existing Condition:

Patients with the following are excluded:

  • Evidence of noncandidal systemic fungal infections.
  • Leukopenia (white blood cell count less than 1000/mm3), or expected to develop leukopenia during the study.
  • Other condition known to be associated with poor ketoconazole absorption, e.g., hypochlorhydria.
  • Leukemia requiring chemotherapy.
  • Any other condition which in the opinion of the investigator would make the patient unsuitable for enrollment.

Concurrent Medication:

Excluded:

  • Warfarin.
  • Immunostimulants.
  • Interferon.
  • Oral or topical antifungal agents.

Concurrent Treatment:

Excluded:

  • Lymphocyte replacement.

Patients with the following are excluded:

  • History of allergy to imidazoles.
  • Abnormalities which may preclude esophagoscopy or endoscopy before or during the study.
  • Inability to tolerate fluconazole or ketoconazole.
  • Inability or unwillingness to give written .
  • \< 2 months.

Prior Medication:

Excluded:

  • Rifampin or ansamycin, pending clarification of drug interactions between these drugs and fluconazole.
  • Warfarin.

Patients must meet the CDC criteria for the diagnosis of AIDS or be otherwise (e.g., , renal transplant) and have a diagnosis of oral candidiasis and/or esophageal symptoms of dysphagia and/or odynophagia.

Illicit or illegal drug use.

Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment

Interventions

06

Study locations

42 sites
  • Good Samaritan Med Ctr
    Phoenix, Arizona 85006, United States
  • Arkansas Children's Hosp
    Little Rock, Arkansas 72202, United States
  • Los Angeles County - USC Med Ctr
    Los Angeles, California 90033, United States
  • Eisenhower Med Ctr
    Rancho Mirage, California 92270, United States
  • ViRx Inc
    San Francisco, California 94103, United States
  • UCSF Hosp
    San Francisco, California 941430654, United States
  • George Washington Univ Med Ctr
    Washington, District of Columbia 20037, United States
  • Regional Oncology Ctr
    Daytona Beach, Florida 32015, United States
  • Ctr for Special Immunology
    Fort Lauderdale, Florida 33308, United States
  • Mem Hosp Hollywood
    Hollywood, Florida 33021, United States
  • Med Ctr Clinic
    Pensacola, Florida 325241151, United States
  • St Petersburg Med Clinics
    St Petersburg, Florida 33705, United States
  • Georgia Baptist Med Ctr
    Atlanta, Georgia 30338, United States
  • DeKalb Gen Hosp
    Decatur, Georgia 30033, United States
  • Gwinnett Med Ctr
    Lawrenceville, Georgia 30245, United States
  • Atlanta Hosp
    Riverdale, Georgia 30274, United States
  • Clayton Gen Hosp
    Riverdale, Georgia 30274, United States
  • Dr Winkler Weinberg
    Roswell, Georgia 30076, United States
  • Univ Hosp
    Boston, Massachusetts 02118, United States
  • Baystate Med Ctr of Springfield
    Springfield, Massachusetts 01199, United States
  • Leila Hosp and Health Care Ctr
    Battle Creek, Michigan 49016, United States
  • Harper Hosp
    Detroit, Michigan 48201, United States
  • Butterworth Hosp
    Grand Rapids, Michigan 49503, United States
  • Holland Community Hosp
    Holland, Michigan 49423, United States
  • Munson Med Ctr
    Traverse City, Michigan 49684, United States
  • Dr Eugene Speck
    Las Vegas, Nevada 89109, United States
  • Univ of New Mexico School of Medicine
    Albuquerque, New Mexico 87131, United States
  • SUNY / Health Sciences Ctr at Brooklyn
    Brooklyn, New York 11203, United States
  • Roswell Park Memorial Institute
    Buffalo, New York 14263, United States
  • Cornell Univ Med Ctr
    New York, New York 10021, United States
  • Bowman Gray School of Medicine / North Carolina Baptist Hosp
    Winston-Salem, North Carolina 27103, United States
  • Buckley Braffman Stern Med Associates
    Philadelphia, Pennsylvania 19107, United States
  • Wilson Brailsford Clinic
    Spartanburg, South Carolina 29304, United States
  • Baroness Erlanger Hosp
    Chattanooga, Tennessee 37403, United States
  • Univ of Tennessee
    Memphis, Tennessee 38163, United States
  • Univ TX Galveston Med Branch
    Galveston, Texas 77550, United States
  • Audie L Murphy Veterans Administration Hosp
    San Antonio, Texas 78284, United States
  • Univ TX San Antonio Health Science Ctr
    San Antonio, Texas 78284, United States
  • Infectious Disease Physicians Inc
    Annandale, Virginia 22203, United States
  • McGuire Virginia Med Ctr
    Richmond, Virginia 23249, United States
  • Virginia Mason Med Ctr
    Seattle, Washington 98101, United States
  • Henderson Gen Hosp
    Hamilton, Ontario, Canada
07

References and documents

Publications

  • Laine L, Dretler RH, Conteas CN, Tuazon C, Koster FM, Sattler F, Squires K, Islam MZ. Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A randomized trial. Ann Intern Med. 1992 Oct 15;117(8):655-60. doi: 10.7326/0003-4819-117-8-655. PubMed 1308663 ↗
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 24, 2005, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00002304
Lead sponsor
Pfizer
First posted
Aug 31, 2001
Last update
Jun 24, 2005
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 1990. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Ketoconazole · Fluconazole

Start the discussion